XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jul. 01, 2018
Jul. 02, 2017
Cash flows from operating activities:    
Net income $ 188,010 $ 260,197
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 33,156 32,474
Amortization 20,177 22,412
Stock-based compensation 17,625 17,312
Deferred taxes 17,312 (3,563)
Provision for excess and obsolete inventory 6,175 5,295
Contingent consideration adjustment (8,468) 2,133
Retirement plan actuarial gains (71) (2,504)
Other 1,168 1,153
Changes in operating assets and liabilities, net of businesses acquired:    
Accounts receivable (179,403) (214,189)
Inventories (21,283) (8,149)
Prepayments and other assets 1,641 4,425
Accounts payable and other accrued expenses (8,155) 34,504
Deferred revenue and customer advances 10,518 5,312
Retirement plans contributions (2,173) (1,983)
Income taxes (26,308) 14,363
Net cash provided by operating activities 49,921 169,192
Cash flows from investing activities:    
Purchases of property, plant and equipment (62,663) (45,967)
Purchases of marketable securities (647,071) (334,819)
Proceeds from sales of marketable securities 829,053 313,254
Proceeds from maturities of marketable securities 469,862 307,607
Acquisition of businesses, net of cash acquired (170,632)  
Net cash provided by investing activities 418,549 240,075
Cash flows from financing activities:    
Issuance of common stock under stock purchase and stock option plans 10,681 15,215
Repurchase of common stock (360,795) (94,328)
Dividend payments (34,682) (27,925)
Payments related to net settlement of employee stock compensation awards (19,751) (12,438)
Payments of contingent consideration (13,571) (1,050)
Net cash used for financing activities (418,118) (120,526)
Effects of exchange rate changes on cash and cash equivalents 189 1,724
Increase in cash and cash equivalents 50,541 290,465
Cash and cash equivalents at beginning of period 429,843 307,884
Cash and cash equivalents at end of period $ 480,384 $ 598,349